M. Štros

Linear models based on business data from the pharmaceutical industry

David Ríha, M. Štros, 2018 .

Marketing dimensions in the prescription pharmaceutical industry: a systematic literature review

Nick Lee, N. Lee, M. Štros, 2015 .

HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells

A. Hampl, M. Štros, J. Jaros, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Relevance of Personal Interaction Factors between Customers and Sales Representatives in the Automotive Business

Timothy Heinze, David Ríha, M. Štros, 2017, Journal of Applied Marketing Theory.

HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction

J. Fajkus, M. Štros, Eva Polanská, 2012, Chromosoma.

Progress in Assays of HMGB1 Levels in Human Plasma—The Potential Prognostic Value in COVID-19

P. Skládal, M. Štros, Eva Polanská, 2022, Biomolecules.

DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences.

M. Štros, M. Štros, 1998, The Journal of biological chemistry.

A model of the prescription-pharmaceuticals sales process

N. Lee, David Ríha, M. Štros, 2017 .

Cloning the genes and DNA binding properties of High Mobility Group B1 (HMGB1) proteins from the human blood flukes Schistosoma mansoni and Schistosoma japonicum.

I. C. de Abreu da Silva, M. Fantappié, S. Verjovski-Almeida, 2006, Gene.

Determinants of specific binding of HMGB1 protein to hemicatenated DNA loops.

M. Štros, L. de Koning, C. Gaillard, 2005, Journal of molecular biology.